Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation

Experimental Hematology

Volumn 33, Issue 6, 2005, Pages 652-659

  Krieger, Sophie ^a   Grunau, Christoph ^b   Sabbah, Michèle ^c   Sola, Brigitte ^a,d  

^a UNIVERSITÉ DE CAEN   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H4; METHYLTRANSFERASE INHIBITOR; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A;

ACETYLATION; ARTICLE; B LYMPHOCYTE; BINDING SITE; CANCER CELL CULTURE; CHROMATIN; CHROMOSOME 11; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; DNA HYPOMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

ACETYLATION; BASE SEQUENCE; CELL LINE, TUMOR; CYCLIN D1; DNA METHYLATION; DNA PRIMERS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; MULTIPLE MYELOMA; PROMOTER REGIONS (GENETICS);

EID: 19444366616     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.03.011     Document Type: Article

References (25)

1. M. Malumbres, and M. Barbacid To cycle or not to cycle: a critical decision in cancer Nat Rev Cancer 1 2001 222 231
2. S. Ortega, M. Malumbres, and M. Barbacid Cyclin-dependent kinases, INK4 inhibitors and cancer Biochim Biophys Acta 1602 2002 73 87
3. R. Donnellan, and R. Chetty Cyclin D1 and human neoplasia Mod Pathol 51 1998 1 7
4. S.M. Mallya, and A. Arnold Cyclin D1 in parathyroid disease Front Biosci 5 2000 d367 d371
5. E. Campo, M. Raffeld, and E.S. Jaffe Mantle-cell lymphoma Semin Hematol 36 1999 115 127
6. P.L. Bergsagel, and W.M. Kuehl Chromosome translocations in multiple myeloma Oncogene 20 2001 5611 5622
7. W. Hoechten-Vollmar, G. Menzel, R. Bartl, R. Lamerz, M. Wick, and D. Seidel Amplification of cyclin D1 in multiple myeloma: clinical and pronostic relevance Br J Haematol 109 2000 30 38
8. S. Soverini, M. Cavo, and L. Cellini Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation Blood 102 2003 1588 1594
9. B. Sola, and X. Troussard Relevance of cyclin D1 level in the pathogenesis of multiple myeloma Blood 102 2003 4245 4246
10. S. Kitazawa, R. Kitazawa, and S. Maeda Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region J Biol Chem 274 1999 28787 28793
11. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
12. X. Troussard, H. Avet-Loiseau, and M. Macro Cyclin D1 expression in patients with multiple myeloma Hematol J 1 2000 181 185
13. B. Herber, M. Truss, M. Beato, and R. Müller Inducible regulatory elements in the human cyclin D1 promoter Oncogene 9 1994 1295 1304
14. M. Sabbah, D. Courilleau, J. Mester, and G. Redeuilh Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element Proc Natl Acad Sci U S A 90 1999 11217 11222
15. O. Tetsu, and F. McCormick β-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 1999 422 426
16. C. Grunau, S.J. Clark, and A. Rosenthal Bisulfite genomic sequencing: systematic investigation of critical experimental parameters Nucleic Acids Res 29 2001 e65
17. P.M. Warnecke, C. Stirzaker, J.R. Melki, D.S. Millar, C.L. Paul, and S.J. Clark Detection and measurement of PCR bias in quantitative methylation analysis of bisulfite-treated DNA Nucleic Acids Res 25 1997 4422 4426
18. D. Umlauf, Y. Goto, and R. Feil Site-specific analysis of histone methylation and acetylation Methods Mol Biol 287 2004 99 120
19. H. Liu, J. Wang, and E.M. Epner Cyclin D1 activation in B cell malignancy: association with changes in histone acetylation, DNA methylation and RNA polymerase II binding to both promoter and distal sequences Blood 104 2004 2505 2513
20. M. Fitzgerald, M. Oshiro, and N. Holtan Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control Neoplasia 5 2003 427 436
21. B. Sola, G. Roué, and F. Duquesne Expression of cyclins D-type in B-chronic lymphoproliferative disorders Leukemia 14 2000 1318 1319
22. T. Tasaka, H. Asou, and R. Munker Methylation of the p16 INK4A gene in multiple myeloma Br J Haematol 101 1998 558 564
23. M. Jaskelioff, and C.L. Peterson Chromatin and transcription: histones continue to make their marks Nat Cell Biol 5 2003 395 399
24. R. Margueron, A. Licznar, G. Lazennec, F. Vignon, and V. Cavailles Oestrogen receptor α increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells J Endocrinol 179 2003 41 53
25. S. Ait-Si-Ali, V. Guasconi, and L. Fritsch A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells EMBO J 23 2004 605 615